Efficacy screening trials of paroxetine, pentoxifylline, riluzole, pramipexole and venlafaxine in cocaine dependence

Addiction

Volumn 100, Issue SUPPL. 1, 2005, Pages 12-22

  Ciraulo, Domenic A ^a   Sarid Segal, Ofra ^a   Knapp, Clifford M ^a   Ciraulo, Ann Marie ^a   Locastro, Joseph ^a   Bloch, Daniel A ^b   Montgomery, Margaret A ^c   Leiderman, Deborah B ^c   Elkashef, Ahmed ^d  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^d NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

Antidepressant; Cocaine dependence; Dopamine agonist; Glutamate inhibitor; Phosphodiesterase inhibitor; SSRI

Indexed keywords

ANTIDEPRESSANT AGENT; BENZOYLECGONINE; COCAINE; DOPAMINE RECEPTOR STIMULATING AGENT; DRUG METABOLITE; GLUTAMATE RECEPTOR ANTAGONIST; LACTOSE; PAROXETINE; PENTOXIFYLLINE; PHOSPHODIESTERASE INHIBITOR; PLACEBO; PRAMIPEXOLE; RILUZOLE; SEROTONIN UPTAKE INHIBITOR; VENLAFAXINE;

ADDICTION; ADULT; ALCOHOL INTOXICATION; ARTICLE; BEHAVIOR THERAPY; CLINICAL ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL TRIAL; COCAINE DEPENDENCE; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG DEPENDENCE; DRUG DEPENDENCE TREATMENT; DRUG DETOXIFICATION; DRUG EFFICACY; DRUG URINE LEVEL; FEMALE; HOSPITALIZATION; HUMAN; MALE; PATIENT COUNSELING; RANDOMIZED CONTROLLED TRIAL; RELIABILITY; RISK ASSESSMENT; SCREENING; SELF REPORT; SIDE EFFECT; SUICIDAL BEHAVIOR; THORAX PAIN; TREATMENT OUTCOME; WITHDRAWAL SYNDROME;

EID: 14944363069     PISSN: 09652140     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2005.00985.x     Document Type: Article

References (35)

1. Batki, S. L., Manfredi, L. B., Jacob, P. III & Jones, R. T. (1993) Fluoxetine for cocaine dependence in methadone maintenance: quantitative plasma and urine cocaine/benzoylecgonine concentrations. Journal of Psychopharmacology, 13, 243-250.
2. Batki, S. L., Washburn, A. M., Delucchi, K. & Jones, R. T. (1996) A controlled trial of fluoxetine in crack cocaine dependence. Drug and Alcohol Dependence, 41, 137-142.
3. Benavides, J., Camelin, J. C., Mitrani, N., Flamand, F., Uzan, A., Legrand, J. J., Gueremy, C. & Le Fur, G. (1985) 2-amino-6- trifluoromethoxybenzothiazole, a possible antagonist of excitatory amino acid neurotransmission. II. Biochemical properties. Neuropharmacology, 24, 1085-1092.
4. Bolden-Watson, C. & Richelson, E. (1993) Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomes. Life Sciences, 52, 1023-1029.
5. Cheramy, A., Romo, R., Godeheu, G., Baruch, P. & Glowinski, J. (1986) in vivo presynaptic control of dopamine release in the cat caudate nucleus. II. Facilitatory or inhibitory influence of 1-glutamate. Neuroscience, 19, 1081-1090.
6. Cornish, J. L., Duffy, P. & Kavilas, P. W. (1999) A role for nucleus accumbens glutamate transmission in the relapse to cocaine-seeking behavior. Neuroscience, 93, 1359-1367.
7. Covi, L., Hess, J. M., Kreiter, N. A. & Haertzen, C. A. (1995) Effects of combined fluoxetine and counseling in the outpatient treatment of cocaine abusers. American Journal of Drug and Alcohol Abuse, 21, 327-344.
8. Di Ciano, P., Underwood, R. J., Hagan, J. J. & Everitt, B. J. (2003) Attenuation of cue-controlled and cocaine-seeking by a selective D3 dopamine receptor antagonist SB-277011-A. Neuropsychopharmacology, 28, 329-338.
9. First, M. B., Spitzer, R. L., Gibbon, M. & Williams, J. B. W. (1996) Structured Clinical Interview for Axis I DSM-IV Disorders-Patient Edition (with Psychotic Screen) (SCID-I/P W/ Psycothic Screen. Version 2.0. Biometrics. New York: Research Department, New York State Psychiatric Institute.
10. Glatz, A. C., Ehrlich, M., Bae, R. S., Clarke, M. J., Quinlan, P. A., Brown, E. C., Rada, P. & Hoebel, B. G. (2002) Inhibition of cocaine self-administration by fluoxetine or D-fenfluramine combined with phentermine. Pharmacology, Biochemistry and Behavior, 71, 197-204.
11. Grabowski, J. J., Rhoades, H. M., Elk, R., Schmitz, J. M., Davis, C., Creson, D. & Kirby, K. (1995) Fluoxetine is ineffective for treatment of cocaine dependence or concurrent opiate and cocaine dependence: two placebo-controlled and double-blind trails. Journal of Clinical Psychopharmacology, 15, 163-174.
12. Hamilton, M. (1959) The assessment of anxiety by rating. British Journal of Psychiatry, 32, 50-55.
13. Hamilton, M. (1960) A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry, 23, 55-61.
14. Hamilton, M. (1967) Development of a rating scale for primary depressive illness. British Journal of Social and Clinical Psychology, 6, 278-296.
15. Heath, P. R. & Shaw, P. J. (2002) Update on the glutamatergic neurotransmitter system and the role of excitotoxicity in amyotrophic lateral sclerosis. Muscle and Nerve, 26, 438-458.
16. Khroyan, T. V., Baker, D. A., Fuchs, R. A., Manders, N. & Neisewander, J. L. ( 1998) Differential effects of 7-OH-DPAT on amphetamine-induced stereotypy and conditioned place preference. Psychopharmacolgy, 139, 332-341.
17. Knapp, C. M., Foye, M., Ciraulo, D. A. & Kornetsky, C. (1998) The type IV phosphodiesterase inhibitors. Ro 20-1724 and rolipram. block the initiation of cocaine self-administration. Pharmacology, Biochemistry and Behavior, 62, 151-158.
18. Lavori, P. W., Bloch, D. A., Bridge, P. T., Leiderman, D. B., LoCastro, J. S. & Somoza, E. (1999) Plans, designs, and analyses for clinical trials of anti-cocaine medications: where we are today. NIDA/VA/SU working group on design and analysis. Journal of Clinical Psychopharmacology, 19, 246-256.
19. Leiderman, D. B., Shoptaw, S., Montgomery, A., Bloch, D. A., Elkashef, A., LoCastro, J. & Vocci, F. (2005) Cocaine Rapid Efficacy Screening Trial (CREST): A paradigm for controlled evaluation of candidate medications for cocaine dependence. Addiction. 100, 1-11.
20. Martin, D., Thompson, M. A. & Nadler, J. V. (1993) The neuroprotective agent riluzole inhibits release of glutamate and aspartate from slices of hippocampal area CA1. European Journal of Pharmacology, 250, 473-476.
21. McDowell, D. M., Levin, F. R., Seracini, A. M. & Nunes, E. V. (2000) Venlafaxine treatment of cocaine abusers with depressive disorders. American Journal of Drug and Alcohol Abuse, 26, 25-31.
22. McLellan, A. T., Luborsky, L., Woody, G. E. & O'Brien, C. P. (1980) An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index. Journal of Nervous and Mental Disease, 168, 26-33.
23. Mierau, J., Schneider, F. J., Ensinger, H. A., Chio, C. L., Lajiness, M. E. & Huff, R. M. (1995) Pramipexole binding and activation of cloned and expressed dopamine D2, D3 and D4 receptors. European Journal of Pharmacology, 290, 29-36.
24. Muller, T., Engels, P. & Fozard, J. R. (1996) Subtypes of the type 4 cAMP phosphodiesterases: structure, regulation and selective inhibition. Trends in Pharmacological Sciences, 17, 294-298.
25. Owens, M. J., Morgan, W. N., Plott, S. J. & Nemeroff, C. B. (1997) Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites. Journal of Pharmacology and Experimental Therapeutics, 283, 1305-1322.
26. Perachon, S., Schwartz, J. C. & Sokoloff, P. (1999) Functional potencies of new antiparkinsonian drugs at recombinant human dopamine D1, D2, and D3 receptors. European Journal of Pharmacology, 366, 293-300.
27. Pilla, M., Perachon, S., Sautel, F., Garridol, F., Mann, A., Wermuth, C. G., Schwartz, J. C., Everitt, B. J. & Sokoloff, P. (1999) Selective inhibition of cocaine-seeking behavior by a partial dopamine D3 receptor agonist. Nature, 400, 371-375.
28. Pollack. M. H. & Rosenbaum, J. F. (1991) Fluoxetine treatment of cocaine abuse in heroin addicts. Journal of Clinical Psychiatry, 52, 31-33.
29. Rosenbaum, J. F. & Fredman, S. J. (1999) Pramipexole treatment for cocaine cravings. American Journal of Psychiatry, 156, 1834.
30. SAS Version 6.12. (1996) Cary, NC: SAS Institute, Inc.
31. Schmilz, J. M., Averill, P. M., Stotts, A. L., Moeller, F. G., Rhoades, H. M. & Grabowski, J. J. (2001 ) Fluoxetine treatment of cocaine-dependent patients with major depressive disorder. Drug and Alcohol Dependence, 63, 207-214.
32. Segal, D. M., Moraes, C. T. & Mash, D. C. (1997) Up-regulation of D3 dopamine receptor mRNA in the nucleus accumbens of human cocaine fatalities. Brain Research. Molecular Brain Research, 45, 335-339.
33. Shafer, R. A. & Levant, B. (1998) The D3 dopamine receptor in cellular and organismal function. Psychopharmacology, 135, 1-16.
34. Shaw, P. J. & Ince, P. G. (1997) Glutamate, excitotoxicity and amyotrophic lateral sclerosis. Journal of Neurology, 244, S3-S14.
35. Staley, J. K. & Mash, D. C. (1996) Adaptive increase in D3 dopamine receptors in the brain reward circuits of human cocaine fatalities. Journal of Neuroscience, 16, 6100-6106.